Search Results for "poverty guidelines"
Displaying 1 - 7 of 7 results. 20 results shown per page. Page 1 of 1.
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
Publication Date
In April 2021 the U.S. Department of Health and Human Services (HHS) issued revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guideline).
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief
Publication Date
How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing? Issue Brief Robin Ghertner and Mir M. Ali U.S. Department of Health and Human Services
Use of Outpatient Pharmacological Treatment Among Infants Born with Neonatal Abstinence Syndrome: Medicaid 2008-2017 Issue Brief
Publication Date
Use of Outpatient Pharmacological Treatment Among Infants Born with Neonatal Abstinence Syndrome: Medicaid 2008-2017 ASPE ISSUE BRIEF Mir M. Ali, Emma Nye, and Kristina West U.S. Department of Health and Human Services
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief
Publication Date
Postpartum Opioid Prescription Fills, Opioid Use Disorder, and Utilization of Medication-Assisted Treatment among Women with Medicaid and Private Health Insurance Coverage Issue Brief Mir M. Ali, Kristina West, and Emma Nye U.S. Department of Health and Human Services
Expanding Access to Family-Centered Medication-Assisted Treatment Issue Brief
Publication Date
Printer Friendly Version in PDF Format (5 PDF pages)
State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment
Publication Date
Printer Friendly Version in PDF Format (55 PDF pages)
Medication Decisions - Right and Wrong
Publication Date
by Bruce Stuart, PhD Becky Briesacher, MA The Peter Lamy Center on Drug Therapy and Aging University of Maryland School of Pharmacy